These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3333881)

  • 41. Critical pharmacokinetic and pharmacodynamic drug-herb interactions in rats between warfarin and pomegranate peel or guava leaves extracts.
    Alnaqeeb M; Mansor KA; Mallah EM; Ghanim BY; Idkaidek N; Qinna NA
    BMC Complement Altern Med; 2019 Jan; 19(1):29. PubMed ID: 30678660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of warfarin, phenylindanedione, tetrachloropyridinol, and chloro-vitamin K1 on prothrombin synthesis and vitamin K metabolism in normal and warfarin-resistant rats.
    Ren P; Laliberte RE; Bell RG
    Mol Pharmacol; 1974 May; 10(3):373-80. PubMed ID: 4851787
    [No Abstract]   [Full Text] [Related]  

  • 43. Puerarin offsets the anticoagulation effect of warfarin in rats by inducing rCyps, upregulating vitamin K epoxide reductase and inhibiting thrombomodulin.
    Ge B; Zhang Z; Lam TT; Zuo Z
    Biopharm Drug Dispos; 2017 Jan; 38(1):33-49. PubMed ID: 27925234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug interactions with warfarin.
    Serlin MJ; Breckenridge AM
    Drugs; 1983 Jun; 25(6):610-20. PubMed ID: 6347619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conversion of vitamin K epoxide to hydroxyvitamin K by liver microsomes from warfarin-resistant rats.
    Nutr Rev; 1983 Aug; 41(8):253-4. PubMed ID: 6355923
    [No Abstract]   [Full Text] [Related]  

  • 46. Warfarin and the vitamin K-dependent gamma-carboxylation system.
    Wallin R; Hutson SM
    Trends Mol Med; 2004 Jul; 10(7):299-302. PubMed ID: 15242675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of warfarin on biological processes other than haemostasis: A review.
    Popov Aleksandrov A; Mirkov I; Ninkov M; Mileusnic D; Demenesku J; Subota V; Kataranovski D; Kataranovski M
    Food Chem Toxicol; 2018 Mar; 113():19-32. PubMed ID: 29353071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Possible interaction between warfarin and fluconazole.
    Gericke KR
    Pharmacotherapy; 1993; 13(5):508-9. PubMed ID: 8247921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacogenetics of warfarin: current status and future challenges.
    Wadelius M; Pirmohamed M
    Pharmacogenomics J; 2007 Apr; 7(2):99-111. PubMed ID: 16983400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated warfarin metabolism in warfarin-resistant roof rats (Rattus rattus) in Tokyo.
    Ishizuka M; Okajima F; Tanikawa T; Min H; Tanaka KD; Sakamoto KQ; Fujita S
    Drug Metab Dispos; 2007 Jan; 35(1):62-6. PubMed ID: 17012541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine.
    Sun H; Zhang T; Wu Z; Wu B
    J Pharm Sci; 2015 Jan; 104(1):244-56. PubMed ID: 25393417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Warfarin resistance. Vitamin K epoxide reductase of Scottish resistance genes is not irreversibly blocked by warfarin.
    Thijssen HH
    Biochem Pharmacol; 1987 Sep; 36(17):2753-7. PubMed ID: 3632704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Case studies in therapeutics: warfarin resistance and inefficacy in a man with recurrent thromboembolism, and anticoagulant-associated priapism.
    Routledge PA; Shetty HG; White JP; Collins P
    Br J Clin Pharmacol; 1998 Oct; 46(4):343-6. PubMed ID: 9803981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacogenetics of target genes across the warfarin pharmacological pathway.
    Lal S; Jada SR; Xiang X; Lim WT; Lee EJ; Chowbay B
    Clin Pharmacokinet; 2006; 45(12):1189-200. PubMed ID: 17112295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Warfarin resistance: biochemical evaluation of a warfarin-resistant wild brown rat.
    Thijssen HH; Janssen CA; Mosterd JJ
    Biochem Pharmacol; 1989 Sep; 38(18):3129-32. PubMed ID: 2783170
    [No Abstract]   [Full Text] [Related]  

  • 56. Azidowarfarin photoaffinity probes of purified rat liver cytochrome P4501A1.
    Obach RS; Spink DC; Chen N; Kaminsky LS
    Arch Biochem Biophys; 1992 Apr; 294(1):215-22. PubMed ID: 1550348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Formation of 3-hydroxy-2,3-dihydrovitamin K1 in vivo: relationship to vitamin K epoxide reductase and warfarin resistance.
    Preusch PC; Suttie JW
    J Nutr; 1984 May; 114(5):902-10. PubMed ID: 6726460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A molecular mechanism for genetic warfarin resistance in the rat.
    Wallin R; Hutson SM; Cain D; Sweatt A; Sane DC
    FASEB J; 2001 Nov; 15(13):2542-4. PubMed ID: 11641264
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The response of the Egyptian spiny mouse (Acomys cahirinus) and two other species of commensal rodents to anticoagulant rodenticides.
    Mahmoud W; Redfern R
    J Hyg (Lond); 1981 Jun; 86(3):329-34. PubMed ID: 7240734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vitamin K and thrombosis.
    Merli GJ; Fink J
    Vitam Horm; 2008; 78():265-79. PubMed ID: 18374199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.